Richard Francis, Teva CEO (Dylan Martinez/Reuters)

Te­va plans staff cuts as it com­mits to ac­cel­er­at­ing growth

Te­va is plan­ning to re­duce its head­count by 8% by 2027, the com­pa­ny an­nounced on Wednes­day, as it en­ters the next phase of its years­long …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA